Notogen Inc.
PrivateTotal Funding Raised
$12.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Notogen Inc. is a biotechnology company that develops regenerative therapeutics for musculoskeletal conditions, specifically targeting degenerative disc disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Notogen Inc. Comparables
Compare Notogen Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spine BioPharma, Inc. | 82% | |
| ReGelTec, Inc. | 82% | |
| Stayble Therapeutics AB | 78% | |
Notogen Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 51% MoM.
- May 2, 2025
Monthly visitors grew 356% MoM, from 263 to 1.2K.
Notogen Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Notogen Inc.'s valuation, stock price, and market status.